Literature DB >> 25447943

Vascular pathology of 20-month-old hypercholesterolemia mice in comparison to triple-transgenic and APPSwDI Alzheimer's disease mouse models.

Lindsay A Hohsfield, Nina Daschil, Greger Orädd, Ingrid Strömberg, Christian Humpel.   

Abstract

Several studies have shown that elevated plasma cholesterol levels (i.e. hypercholesterolemia) serve as a risk factor for late-onset Alzheimer's disease (AD). However, it remains unclear how hypercholesterolemia may contribute to the onset and progression of AD pathology. In order to determine the role of hypercholesterolemia at various stages of AD, we evaluated the effects of high cholesterol diet (5% cholesterol) in wild-type (WT; C57BL6) and triple-transgenic AD (3xTg-AD; Psen1, APPSwe, tauB301L) mice at 7, 14, and 20 months. The transgenic APP-Swedish/Dutch/Iowa AD mouse model (APPSwDI) was used as a control since these animals are more pathologically-accelerated and are known to exhibit extensive plaque deposition and cerebral amyloid angiopathy. Here, we describe the effects of high cholesterol diet on: (1) cognitive function and stress, (2) AD-associated pathologies, (3) neuroinflammation, (4) blood–brain barrier disruption and ventricle size, and (5) vascular dysfunction. Our data show that high dietary cholesterol increases weight, slightly impairs cognitive function, promotes glial cell activation and complement-related pathways, enhances the infiltration of blood-derived proteins and alters vascular integrity, however, it does not induce AD-related pathologies. While normal-fed 3xTg-AD mice display a typical AD-like pathology in addition to severe cognitive impairment and neuroinflammation at 20 months of age, vascular alterations are less pronounced. No microbleedings were seen by MRI, however, the ventricle size was enlarged. Triple-transgenic AD mice, on the other hand, fed a high cholesterol diet do not survive past 14 months of age. Our data indicates that cholesterol does not markedly potentiate AD-related pathology, nor does it cause significant impairments in cognition. However, it appears that high cholesterol diet markedly increases stress-related plasma corticosterone levels as well as some vessel pathologies. Together, our findings represent the first demonstration of prolonged high cholesterol diet and the examination of its effects at various stages of cerebrovascular- and AD-related disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25447943      PMCID: PMC4311145          DOI: 10.1016/j.mcn.2014.10.006

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  63 in total

Review 1.  The blood-brain barrier in health and chronic neurodegenerative disorders.

Authors:  Berislav V Zlokovic
Journal:  Neuron       Date:  2008-01-24       Impact factor: 17.173

Review 2.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

3.  Biochemical and morphological characterization of the AβPP/PS/tau triple transgenic mouse model and its relevance to sporadic Alzheimer's disease.

Authors:  Jesse M Hunter; William J Bowers; Chera L Maarouf; Michael A Mastrangelo; Ian D Daugs; Tyler A Kokjohn; Walter M Kalback; Dean C Luehrs; Jon Valla; Thomas G Beach; Alex E Roher
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

4.  Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model.

Authors:  L M Refolo; B Malester; J LaFrancois; T Bryant-Thomas; R Wang; G S Tint; K Sambamurti; K Duff; M A Pappolla
Journal:  Neurobiol Dis       Date:  2000-08       Impact factor: 5.996

Review 5.  Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.

Authors:  Abhay P Sagare; Robert D Bell; Berislav V Zlokovic
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

6.  A lifespan MRI evaluation of ventricular enlargement in normal aging mice.

Authors:  Chiao-Chi V Chen; Yu-Ying Tung; Chen Chang
Journal:  Neurobiol Aging       Date:  2010-02-05       Impact factor: 4.673

Review 7.  Animal models of amyloid-beta-related pathologies in Alzheimer's disease.

Authors:  Ola Philipson; Anna Lord; Astrid Gumucio; Paul O'Callaghan; Lars Lannfelt; Lars N G Nilsson
Journal:  FEBS J       Date:  2010-02-03       Impact factor: 5.542

8.  Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice.

Authors:  Lauren M Billings; Salvatore Oddo; Kim N Green; James L McGaugh; Frank M LaFerla
Journal:  Neuron       Date:  2005-03-03       Impact factor: 17.173

9.  Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits.

Authors:  Celine Ullrich; Michael Pirchl; Christian Humpel
Journal:  Mol Cell Neurosci       Date:  2010-08-06       Impact factor: 4.314

10.  Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.

Authors:  Lesley Jones; Peter A Holmans; Marian L Hamshere; Denise Harold; Valentina Moskvina; Dobril Ivanov; Andrew Pocklington; Richard Abraham; Paul Hollingworth; Rebecca Sims; Amy Gerrish; Jaspreet Singh Pahwa; Nicola Jones; Alexandra Stretton; Angharad R Morgan; Simon Lovestone; John Powell; Petroula Proitsi; Michelle K Lupton; Carol Brayne; David C Rubinsztein; Michael Gill; Brian Lawlor; Aoibhinn Lynch; Kevin Morgan; Kristelle S Brown; Peter A Passmore; David Craig; Bernadette McGuinness; Stephen Todd; Clive Holmes; David Mann; A David Smith; Seth Love; Patrick G Kehoe; Simon Mead; Nick Fox; Martin Rossor; John Collinge; Wolfgang Maier; Frank Jessen; Britta Schürmann; Reinhard Heun; Heike Kölsch; Hendrik van den Bussche; Isabella Heuser; Oliver Peters; Johannes Kornhuber; Jens Wiltfang; Martin Dichgans; Lutz Frölich; Harald Hampel; Michael Hüll; Dan Rujescu; Alison M Goate; John S K Kauwe; Carlos Cruchaga; Petra Nowotny; John C Morris; Kevin Mayo; Gill Livingston; Nicholas J Bass; Hugh Gurling; Andrew McQuillin; Rhian Gwilliam; Panos Deloukas; Ammar Al-Chalabi; Christopher E Shaw; Andrew B Singleton; Rita Guerreiro; Thomas W Mühleisen; Markus M Nöthen; Susanne Moebus; Karl-Heinz Jöckel; Norman Klopp; H-Erich Wichmann; Eckhard Rüther; Minerva M Carrasquillo; V Shane Pankratz; Steven G Younkin; John Hardy; Michael C O'Donovan; Michael J Owen; Julie Williams
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

View more
  13 in total

1.  In Vivo Detection of Gray Matter Neuropathology in the 3xTg Mouse Model of Alzheimer's Disease with Diffusion Tensor Imaging.

Authors:  Wanda M Snow; Ryan Dale; Zoe O'Brien-Moran; Richard Buist; Danial Peirson; Melanie Martin; Benedict C Albensi
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

2.  Transcriptional signatures of brain aging and Alzheimer's disease: What are our rodent models telling us?

Authors:  Kendra E Hargis; Eric M Blalock
Journal:  Behav Brain Res       Date:  2016-05-04       Impact factor: 3.332

3.  Non-alcoholic fatty liver disease induces signs of Alzheimer's disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model.

Authors:  Do-Geun Kim; Antje Krenz; Leon E Toussaint; Kirk J Maurer; Sudie-Ann Robinson; Angela Yan; Luisa Torres; Margaret S Bynoe
Journal:  J Neuroinflammation       Date:  2016-01-05       Impact factor: 8.322

4.  Comparative benefits of simvastatin and exercise in a mouse model of vascular cognitive impairment and dementia.

Authors:  Lianne J Trigiani; Jessika Royea; Xin-Kang Tong; Edith Hamel
Journal:  FASEB J       Date:  2019-09-26       Impact factor: 5.834

5.  Alpha-Smooth Muscle Actin mRNA and Protein Are Increased in Isolated Brain Vessel Extracts of Alzheimer Mice.

Authors:  Bianca Hutter-Schmid; Christian Humpel
Journal:  Pharmacology       Date:  2016-07-28       Impact factor: 2.547

6.  Group 2 innate lymphoid cells are numerically and functionally deficient in the triple transgenic mouse model of Alzheimer's disease.

Authors:  Ivan Ting Hin Fung; Yuanyue Zhang; Damian S Shin; Poornima Sankar; Xiangwan Sun; Shanti S D'Souza; Renjie Song; Marcy L Kuentzel; Sridar V Chittur; Kristen L Zuloaga; Qi Yang
Journal:  J Neuroinflammation       Date:  2021-07-06       Impact factor: 8.322

7.  Organotypic brain slice cultures as a model to study angiogenesis of brain vessels.

Authors:  Bianca Hutter-Schmid; Kathrin M Kniewallner; Christian Humpel
Journal:  Front Cell Dev Biol       Date:  2015-09-02

8.  Association of neck circumference and cognitive impairment among Chinese elderly.

Authors:  Jin-Mei Chen; Qing-Wei Li; Guo-Xin Jiang; Shu-Jun Zeng; Jun Shen; Ji Sun; Dan-Hong Wu; Qi Cheng
Journal:  Brain Behav       Date:  2018-02-14       Impact factor: 2.708

9.  Differential Hyperphosphorylation of Tau-S199, -T231 and -S396 in Organotypic Brain Slices of Alzheimer Mice. A Model to Study Early Tau Hyperphosphorylation Using Okadaic Acid.

Authors:  Bettina M Foidl; Christian Humpel
Journal:  Front Aging Neurosci       Date:  2018-04-19       Impact factor: 5.750

Review 10.  Neurovascular dysfunction in vascular dementia, Alzheimer's and atherosclerosis.

Authors:  Osman Shabir; Jason Berwick; Sheila E Francis
Journal:  BMC Neurosci       Date:  2018-10-17       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.